Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Mar;53(3):378-87.
doi: 10.1097/QAI.0b013e3181b7222e.

A randomized trial of enhanced HIV risk-reduction and vaccine trial education interventions among HIV-negative, high-risk women who use noninjection drugs: the UNITY study

Beryl A Koblin  1 , Sebastian Bonner, Donald R Hoover, Guozhen Xu, Debbie Lucy, Princess Fortin, Sara Putnam, Mary H Latka
Affiliations
Randomized Controlled Trial

A randomized trial of enhanced HIV risk-reduction and vaccine trial education interventions among HIV-negative, high-risk women who use noninjection drugs: the UNITY study

Beryl A Koblin et al. J Acquir Immune Defic Syndr. 2010 Mar.

Abstract

Background: Limited data are available on interventions to reduce sexual risk behaviors and increase knowledge of HIV vaccine trial concepts in high-risk populations eligible to participate in HIV vaccine efficacy trials.

Methods: The UNITY Study was a 2-arm randomized trial to determine the efficacy of enhanced HIV risk-reduction and vaccine trial education interventions to reduce the occurrence of unprotected vaginal sex acts and increase HIV vaccine trial knowledge among 311 HIV-negative noninjection drug using women. The enhanced vaccine education intervention using pictures along with application vignettes and enhanced risk-reduction counseling consisting of 3 one-on-one counseling sessions were compared with standard conditions. Follow-up visits at 1 week and 1, 6, and 12 months after randomization included HIV testing and assessment of outcomes.

Results: During follow-up, the percent of women reporting sexual risk behaviors declined significantly but did not differ significantly by study arm. Knowledge of HIV vaccine trial concepts significantly increased but did not significantly differ by study arm. Concepts about HIV vaccine trials not adequately addressed by either condition included those related to testing a vaccine for both efficacy and safety, guarantees about participation in future vaccine trials, assurances of safety, medical care, and assumptions about any protective effect of a test vaccine.

Conclusions: Further research is needed to boost educational efforts and strengthen risk-reduction counseling among high-risk noninjection drug using women.

Trial registration: ClinicalTrials.gov NCT00150098.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of trial, UNITY Study
Figure 2
Figure 2
Percent of women reporting sexual risk behaviors by study arm and visit
Figure 3
Figure 3
Mean number of HIV vaccine knowledge items correct by study arm and visit
See this image and copyright information in PMC

References

    1. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS. Estimation of HIV incidence in the United States. JAMA. 2008;300:520–529. - PMC - PubMed
    1. Subpopulation estimates from the HIV incidence surveillance system--United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57:985–989. - PubMed
    1. Gollub EL. A neglected population: drug-using women and women’s methods of HIV/STI prevention. AIDS Educ Prev. 2008;20:107–120. - PubMed
    1. Ross MW, Hwang LY, Zack C, Bull L, Williams ML. Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int J STD AIDS. 2002;13:769–774. - PubMed
    1. Sterk CE, Theall KP, Elifson KW. Who’s getting the message? Intervention response rates among women who inject drugs and/or smoke crack cocaine. Prev Med. 2003;37:119–128. - PubMed

Publication types

Associated data